Cardiopulmonary fitness assessment is a valuable resource to obtain quantitative indicators of an individual's physical performance. The cardiopulmonary exercise test (CPX), considered the gold standard test for this evaluation, is costly and difficult to be accessed by the general population. In order to make this evaluation more accessible, and to better reflect the performance of daily life activities, alternative tests were proposed. Morbidly obese patients present limitations that impair physical performance assessment and could benefit from a test of shorter duration, provided it is validated. This observational study aimed to validate the two-minute step test (2MST) as a tool to evaluate functional capacity (FC) in obese with comorbidities and morbidly obese patients, compared the 2MST with CPX as a measure of physical performance, and developed a predictive equation to estimate peak oxygen uptake (VO2) in the 2MST. The CPX and the 2MST were performed and metabolic and ventilatory parameters were recorded in 31 obese individuals (BMI>35 kg/m2). Pearson correlation and multiple linear regression analyses were performed to evaluate the peak VO2 best predictors. Bland-Altman analysis was performed to assess the agreement between the two methods. Peak VO2 measured by CPX and 2MST showed a strong correlation (r=0.70, P<0.001) and there was a moderate correlation between peak VO2 of the 2MST and the number of up-and-down step cycles (UDS) (r=0.55; P=0.01). The reference equation obtained was: VO2 (mL·kg-1·min-1) = 13.341 + 0.138 × total UDS – (0.183 × BMI), with an estimated standard error of 1.3 mL·kg-1·min-1. The 2MST is a viable, practical, and easily accessible test for FC. UDS and BMI can predict peak VO2 satisfactorily.
Purpose: To evaluate interrater and intrarater reliability of chest wall mobility using cirtometry in individuals with asthma and controls. Methods: Twenty-six controlled individuals with asthma group (AG) and 12 healthy individuals control group (CG) underwent chest wall mobility assessed by cirtometry. The measurements were performed manually by 2 independent evaluators at 3 levels: axillary, xiphoid and abdominal using a tape, in 2 different days. For the analyses, the average of 3 measurements and the highest value were considered. Results: Interrater reliability in AG showed acceptable intraclass correlation coefficient (ICC) for the axillary (0.76 and 0.75), good for the xiphoid (0.91 and 0.93), and abdominal level (0.91 and 0.91) for the average and highest value. In CG, ICC values were acceptable for the 3 levels: axillary (0.64 and 0.71), xiphoid (0.66 and 0.93), and abdominal level (0.61 and 0.91) also for the average and highest value. The analysis with the mean and the highest values found it acceptable for the axillary and good for the xiphoid and abdominal levels. Intrarater ICC was good for all levels in AG, axillary (0.86), xiphoid (0.93), and abdominal (0.96), for both evaluators. In CG, for evaluator 1, it was acceptable for the axillary and good for the xiphoid and abdominal levels. Regarding evaluator 2, it was good for the axillary and xiphoid and acceptable at the abdominal level. Conclusion: Cirtometry is a reliable tool to measure the chest wall mobility in controlled asthma individuals and in healthy individuals. The average of the 3 measurements or the highest value of the evaluations may be considered in clinical assessments. Axillary mobility was lower in the asthma group.